These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 19512981

  • 21. Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism.
    Gorman JM, Kent J, Martinez J, Browne S, Coplan J, Papp LA.
    Arch Gen Psychiatry; 2001 Feb; 58(2):125-31. PubMed ID: 11177114
    [Abstract] [Full Text] [Related]

  • 22. Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects.
    Poma SZ, Milleri S, Squassante L, Nucci G, Bani M, Perini GI, Merlo-Pich E.
    J Psychopharmacol; 2005 Sep; 19(5):494-503. PubMed ID: 16166187
    [Abstract] [Full Text] [Related]

  • 23. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ.
    Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
    [Abstract] [Full Text] [Related]

  • 24. Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks.
    Nardi AE, Valença AM, Nascimento I, Mezzasalma MA, Zin WA.
    Psychiatry Res; 2000 May 15; 94(2):179-84. PubMed ID: 10808043
    [Abstract] [Full Text] [Related]

  • 25. Escitalopram.
    Burke WJ.
    Expert Opin Investig Drugs; 2002 Oct 15; 11(10):1477-86. PubMed ID: 12387707
    [Abstract] [Full Text] [Related]

  • 26. Autonomic reactivity of panic patients during a CO2 inhalation procedure.
    Bystritsky A, Craske M, Maidenberg E, Vapnik T, Shapiro D.
    Depress Anxiety; 2000 Oct 15; 11(1):15-26. PubMed ID: 10723631
    [Abstract] [Full Text] [Related]

  • 27. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
    Bertani A, Perna G, Arancio C, Caldirola D, Bellodi L.
    J Clin Psychopharmacol; 1997 Apr 15; 17(2):97-101. PubMed ID: 10950471
    [Abstract] [Full Text] [Related]

  • 28. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals.
    Brambilla F, Perini G, Serra M, Pisu MG, Zanone S, Toffanin T, Milleri S, Garcia CS, Biggio G.
    Psychoneuroendocrinology; 2013 Oct 15; 38(10):2234-42. PubMed ID: 23702252
    [Abstract] [Full Text] [Related]

  • 29. Aberrant respiratory sensitivity to CO(2) as a trait of familial panic disorder.
    Coryell W, Fyer A, Pine D, Martinez J, Arndt S.
    Biol Psychiatry; 2001 Apr 01; 49(7):582-7. PubMed ID: 11297715
    [Abstract] [Full Text] [Related]

  • 30. Effects of Cytochrome P450 2C19 Genetic Polymorphisms on Responses to Escitalopram and Levels of Brain-Derived Neurotrophic Factor in Patients With Panic Disorder.
    He Q, Mei Y, Liu Y, Yuan Z, Zhang J, Yan H, Shen L, Zhang Y.
    J Clin Psychopharmacol; 2019 Apr 01; 39(2):117-123. PubMed ID: 30742590
    [Abstract] [Full Text] [Related]

  • 31. Alprazolam blockade of CO2-provoked panic in patients with panic disorder.
    Sanderson WC, Wetzler S, Asnis GM.
    Am J Psychiatry; 1994 Aug 01; 151(8):1220-2. PubMed ID: 8037259
    [Abstract] [Full Text] [Related]

  • 32. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
    Mochcovitch MD, Nardi AE.
    Expert Rev Neurother; 2010 Aug 01; 10(8):1285-93. PubMed ID: 20662754
    [Abstract] [Full Text] [Related]

  • 33. The effect of successful treatment on the emotional and physiological response to carbon dioxide inhalation in patients with panic disorder.
    Gorman JM, Martinez J, Coplan JD, Kent J, Kleber M.
    Biol Psychiatry; 2004 Dec 01; 56(11):862-7. PubMed ID: 15576063
    [Abstract] [Full Text] [Related]

  • 34. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH, Goa KL.
    CNS Drugs; 1997 Aug 01; 8(2):163-88. PubMed ID: 23338224
    [Abstract] [Full Text] [Related]

  • 35. The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: a prospective 6-month follow-up study.
    Peh AL, Nieng CH, Ling YH, Kheng TW, Neng TS, Koon OG.
    Asian J Psychiatr; 2013 Jun 01; 6(3):256-7. PubMed ID: 23642988
    [No Abstract] [Full Text] [Related]

  • 36. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH.
    J Clin Psychiatry; 2009 Nov 01; 70(11):1563-70. PubMed ID: 19814948
    [Abstract] [Full Text] [Related]

  • 37. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
    Kellner M, Muhtz C, Demiralay C, Husemann J, Koelsch W, Yassouridis A, Wiedemann K.
    J Psychiatr Res; 2009 Mar 01; 43(6):642-8. PubMed ID: 18930474
    [Abstract] [Full Text] [Related]

  • 38. Pharmacological approaches to the management of panic disorder in older patients: a systematic review.
    Caldirola D, De Donatis D, Alciati A, Daccò S, Perna G.
    Expert Rev Neurother; 2023 Mar 01; 23(11):1013-1029. PubMed ID: 37676054
    [Abstract] [Full Text] [Related]

  • 39. The effect of citalopram in panic disorder.
    Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T.
    Br J Psychiatry; 1997 Jun 01; 170():549-53. PubMed ID: 9330022
    [Abstract] [Full Text] [Related]

  • 40. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ, Gergel I, Bose A.
    J Clin Psychiatry; 2002 Apr 01; 63(4):331-6. PubMed ID: 12000207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.